Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
暂无分享,去创建一个
Takaya Nagasaki | Masayasu Hara | Hiroki Takahashi | Hiroki Takahashi | H. Takeyama | M. Hara | Hiromitsu Takeyama | Kazuyoshi Shiga | Takafumi Sato | T. Nagasaki | Takafumi Sato | Kazuyoshi Shiga | Hiroki Takahashi
[1] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[2] S. Ghatak,et al. Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan* , 2003, Journal of Biological Chemistry.
[3] E. Lengyel,et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.
[4] Robert A. Weinberg,et al. Heterogeneity of stromal fibroblasts in tumor , 2007 .
[5] Lena Claesson-Welsh,et al. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. , 2006, Experimental cell research.
[6] R. Swann,et al. Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy , 2013, Clinical Cancer Research.
[7] F. Strutz,et al. Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.
[8] A. G. de Herreros,et al. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival , 2015, Clinical Cancer Research.
[9] R. Sikes,et al. Insidious Changes in Stromal Matrix Fuel Cancer Progression , 2014, Molecular Cancer Research.
[10] A. Larue,et al. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment. , 2015, World journal of stem cells.
[11] K. Oda,et al. Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo , 2014, PloS one.
[12] P. Ji,et al. Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer , 2011, Medical oncology.
[13] E. Raymond,et al. Targeting cancer cell metabolism in pancreatic adenocarcinoma , 2015, Oncotarget.
[14] P. Fortina,et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.
[15] R. Markwald,et al. Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.
[16] M. Vaccaro,et al. Autophagy, Warburg, and Warburg Reverse Effects in Human Cancer , 2014, BioMed research international.
[17] M. Hatano,et al. DA-Raf-Mediated Suppression of the Ras—ERK Pathway Is Essential for TGF-β1-Induced Epithelial—Mesenchymal Transition in Alveolar Epithelial Type 2 Cells , 2015, PloS one.
[18] C. Bucana,et al. Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential , 2006, International journal of cancer.
[19] C. López-Otín,et al. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). , 1997, European journal of biochemistry.
[20] T. Golub,et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.
[21] Jiwang Zhang,et al. Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer , 2014, Oncogene.
[22] Philip Levy Ho,et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.
[23] C. Heldin,et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. , 2001, Cancer research.
[24] R. Kalluri,et al. Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment , 2007, Journal of cellular biochemistry.
[25] Lianyu Chen,et al. Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer , 2014, PloS one.
[26] Hiroyuki Tomita,et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.
[27] M. Fukayama,et al. Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] E. Giannoni,et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression , 2014, Oncogene.
[29] R. Weinberg,et al. Heterogeneity of stromal fibroblasts in tumors. , 2007, Cancer biology & therapy.
[30] M. Loeffler,et al. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.
[31] G. Kroemer,et al. Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells , 2012, Cell Death and Disease.
[32] J. Bouchal,et al. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.
[33] Jinxiang Tan,et al. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. , 2011, The International journal of developmental biology.
[34] Olivier De Wever,et al. Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer , 2015, Front. Oncol..
[35] R. Bhatia,et al. Stem Cell Quiescence , 2011, Clinical Cancer Research.
[36] A. Molinolo,et al. Carcinoma‐associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF‐2/FGFR‐2 axis , 2008, International journal of cancer.
[37] K. Smalley,et al. Fibroblast-mediated drug resistance in cancer. , 2013, Biochemical pharmacology.
[38] J. Rubin,et al. Characterization of Transplanted Green Fluorescent Protein+ Bone Marrow Cells into Adipose Tissue , 2008, Stem cells.
[39] E. Hay,et al. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.
[40] A. Larue,et al. Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. , 2006, Blood.
[41] B. Curti. Physical barriers to drug delivery in tumors. , 1993, Critical reviews in oncology/hematology.
[42] M. Dewhirst,et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-β and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation , 2006, British Journal of Cancer.
[43] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[44] E. Motrescu,et al. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle , 2008, Biological chemistry.
[45] E. Giannoni,et al. Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells , 2013, Cell cycle.
[46] H. Takeyama,et al. Relationship between inflammation and cancer progression: Recent advances in interleukin-6 signaling and its blockage in cancer therapy , 2014 .
[47] J. Wang,et al. IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer , 2014, Oncogene.
[48] G. Fan,et al. Cancer-Associated Fibroblasts in a Human HEp-2 Established Laryngeal Xenografted Tumor Are Not Derived from Cancer Cells through Epithelial-Mesenchymal Transition, Phenotypically Activated but Karyotypically Normal , 2015, PloS one.
[49] B. Teicher,et al. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.
[50] I. Ben-Sahra,et al. Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? , 2010, Molecular Cancer Therapeutics.
[51] F. Sotgia,et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors , 2010, Cell cycle.
[52] T. Sjöblom,et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. , 2013, Cancer research.
[53] J. Folkman,et al. Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.
[54] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[55] Lei Mu,et al. Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer , 2015, PloS one.
[56] R. Kalluri,et al. The role of endothelial-to-mesenchymal transition in cancer progression , 2008, British Journal of Cancer.
[57] Chen Li-rong,et al. Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer. , 2012, Breast care.
[58] S. Eccles,et al. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells , 2014, BMC Cancer.
[59] E. Neilson,et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.
[60] Douglas B. Evans,et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.
[61] Donald R Schwartz,et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. , 2003, Cancer cell.
[62] Ming Liu,et al. Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells , 2012, Oncology letters.
[63] A. Molinolo,et al. Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth , 2010, BMC Cancer.
[64] J. Wang,et al. IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer. , 2014, Oncogene.
[65] Kunwei Shen,et al. Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.
[66] Robert A. Weinberg,et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.
[67] B. Hinz,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.
[68] N. Asai,et al. Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. , 2015, Cancer Research.
[69] Tong-Cun Zhang,et al. The role of endothelial–mesenchymal transition in development and pathological process , 2012, IUBMB life.
[70] S. Yeh,et al. BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts , 2015, International journal of oncology.
[71] A. Larue,et al. Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin. , 2012, International journal of clinical and experimental pathology.
[72] L. Fabris,et al. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. , 2013, Oncology reports.
[73] W. Schürch,et al. Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.
[74] A. Roberts,et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β , 2005, Journal of Cell Science.
[75] B. Hennessy,et al. Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.
[76] E. Itoi,et al. Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours , 2009, Histopathology.
[77] A. Aboussekhra,et al. Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes , 2014, PloS one.
[78] J. Houghton,et al. Tumor microenvironment: The role of the tumor stroma in cancer , 2007, Journal of cellular biochemistry.
[79] A. Geinoz,et al. The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.
[80] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[81] Mikinori Sato,et al. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction , 2013, British Journal of Cancer.
[82] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[83] K. Chayama,et al. Anti‐stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model , 2011, International journal of cancer.
[84] J. Park,et al. Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.
[85] L. Xiao,et al. The cancer-associated fibroblasts and drug resistance. , 2015, European review for medical and pharmacological sciences.
[86] K. Sukhdeo,et al. Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A , 2013, The Journal of experimental medicine.
[87] C. Tiribelli,et al. The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis , 2015, BMC Cancer.
[88] A. Jungbluth,et al. Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors , 2011, Biological chemistry.
[89] M. Mizumoto,et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. , 1998, British Journal of Cancer.
[90] Olivier De Wever,et al. Stromal myofibroblasts are drivers of invasive cancer growth , 2008, International journal of cancer.
[91] R. Lin,et al. Rapamycin and mTOR kinase inhibitors , 2008, Journal of chemical biology.
[92] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[93] R. Kalluri,et al. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. , 2011, Genes & cancer.
[94] J. Reid,et al. A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer , 2015, BMC Cancer.
[95] Li Yang,et al. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells , 2015, Breast Cancer Research.
[96] A. Orimo,et al. Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target , 2013, Cancers.
[97] F. Jerhammar,et al. Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase–Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells , 2012, Molecular Cancer Research.
[98] Liang Xie,et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.
[99] J. Bruun,et al. Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation , 2015, Front. Oncol..
[100] M. Kudo,et al. Signaling Pathways Governing Tumor Angiogenesis , 2011, Oncology.
[101] P. Hahnfeldt,et al. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.
[102] O. De Wever,et al. Differential secretome analysis of cancer‐associated fibroblasts and bone marrow‐derived precursors to identify microenvironmental regulators of colon cancer progression , 2013, Proteomics.
[103] T. Ochiya,et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. , 2003, Biochemical and biophysical research communications.
[104] Mark W. Kieran,et al. Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.
[105] Yihai Cao,et al. R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways , 2008, Journal of Molecular Medicine.
[106] W. Cavenee,et al. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. , 1999, Cancer research.
[107] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[108] Toshimichi Yoshida,et al. Tenascin-C and integrins in cancer , 2015, Cell adhesion & migration.
[109] R. Palmqvist,et al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis , 2013, Tumor Biology.
[110] M. Papi,et al. Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness , 2012, PloS one.
[111] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[112] Fei Xing,et al. Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.
[113] Yu Zhao,et al. Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis. , 2015, International journal of clinical and experimental medicine.
[114] James O. Jones,et al. Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .
[115] T. Hunt,et al. Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts , 2004, Cancer Research.
[116] A. Vincent-Salomon,et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.
[117] B. Chauffert,et al. In vivo and in vitro invasiveness of a rat colon‐cancer cell line maintaining E‐cadherin expression: An enhancing role of tumor‐associated myofibroblasts , 1994, International journal of cancer.
[118] Robert A. Gatenby,et al. Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.
[119] Rakesh K. Jain,et al. Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.
[120] W. Dalton,et al. Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies , 2004, Cancer and Metastasis Reviews.
[121] Tobias Sjöblom,et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. , 2002, Cancer research.
[122] M. Bissell,et al. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion , 2001, Breast Cancer Research.